| Adipose-derived mesenchymal stem cell therapy in the treatment of knee osteoarthritis: a randomized controlled trial |
35 |
| Quality control guidelines for clinical-grade human induced pluripotent stem cell lines |
20 |
| Human adipose-derived mesenchymal stem cells for osteoarthritis: a pilot study with long-term follow-up and repeated injections |
18 |
| Extracellular vesicles derived from mesenchymal cells: perspective treatment for cutaneous wound healing in pediatrics |
11 |
| Channels in a porous scaffold: a new player for vascularization |
9 |
| First decade of clinical trials and published studies with mesenchymal stromal cells from umbilical cord tissue |
9 |
| Nomenclature and heterogeneity: consequences for the use of mesenchymal stem cells in regenerative medicine |
9 |
| Exploration of 2-deoxy-D-ribose and 17 beta-Estradiol as alternatives to exogenous VEGF to promote angiogenesis in tissue-engineered constructs |
8 |
| Advances in perinatal stem cells research: a precious cell source for clinical applications |
8 |
| A contemporary view of platelet-rich plasma therapies: moving toward refined clinical protocols and precise indications |
8 |
| The FDA and the US direct-to-consumer marketplace for stem cell interventions: a temporal analysis |
7 |
| Biologic therapies to enhance intervertebral disc repair |
7 |
| Stem cell culture conditions and stability: a joint workshop of the PluriMes Consortium and Pluripotent Stem Cell Platform |
6 |
| Application of 3D-printed patient-specific skeletal implants augmented with autologous skeletal stem cells |
6 |
| Application of PLGA/FGF-2 coaxial microfibers in spinal cord tissue engineering: an in vitro and in vivo investigation |
6 |
| Rapid change of a cohort of 570 unproven stem cell clinics in the USA over 3 years |
6 |
| Anticipating the clinical adoption of regenerative medicine: building institutional readiness in the UK |
6 |
| Direct-to-consumer marketing of stem cell interventions by Canadian businesses |
6 |
| Pure platelet-rich plasma and supernatant of calcium-activated P-PRP induce different phenotypes of human macrophages |
5 |
| Platelet-rich plasma lyophilization enables growth factor preservation and functionality when compared with fresh platelet-rich plasma |
5 |
| Dental pulp stem cells for bone tissue engineering: a review of the current literature and a look to the future |
5 |
| Biosafety and bioefficacy assessment of human mesenchymal stem cells: what do we know so far? |
5 |
| Evolving therapies for Fuchs' endothelial dystrophy |
5 |
| Better therapeutic potential of bone marrow-derived mesenchymal stem cells compared with chorionic villi-derived mesenchymal stem cells in airway injury model |
4 |
| An insight into the whole transcriptome profile of four tissue-specific human mesenchymal stem cells |
4 |
| Toward a unified theory of aging and regeneration |
4 |
| Comparison of in vivo remodeling of urinary bladder matrix and acellular dermal matrix in an ovine model |
4 |
| The olfactory mucosa: a potential source of stem cells for hearing regeneration |
4 |
| Heart valve tissue engineering: an overview of heart valve decellularization processes |
4 |
| Recent advances in 3D bioprinting for the regeneration of functional cartilage |
4 |
| The effect of cartilage extracellular matrix particle size on the chondrogenic differentiation of bone marrow mesenchymal stem cells |
4 |
| Cell therapy-processing economics: small-scale microfactories as a stepping stone toward large-scale macrofactories |
4 |
| Advances in addressing full-thickness skin defects: a review of dermal and epidermal substitutes |
4 |
| Regenerative medicine in lower limb reconstruction |
4 |
| Evaluating the efficacy of tissue-engineered human amniotic membrane in the treatment of myocardial infarction |
4 |
| Stem and progenitor cell microenvironment for bone regeneration and repair |
3 |
| Lessons for reviewing clinical trials using induced pluripotent stem cells: examining the case of a first-in-human trial for age-related macular degeneration |
3 |
| Efficiency of mesenchymal stem cells in treatment of urinary incontinence: a systematic review on animal models |
3 |
| Mapping theme trends and knowledge structure on adipose-derived stem cells: a bibliometric analysis from 2003 to 2017 |
3 |
| The effect ofmesenchymal stem cell-secreted factors on airway epithelial repair |
3 |
| Retrorectus repair of incisional ventral hernia with urinary bladder matrix reinforcement in a long-term porcine model |
3 |
| Conditioned medium from 3D culture system of stromal vascular fraction cells accelerates wound healing in diabetic rats |
3 |
| Advances in electrical and magnetic stimulation on nerve regeneration |
3 |
| Biochemical characterization of pure dehydrated binate amniotic membrane: role of cytokines in the spotlight |
3 |
| Autologous plasma rich in growth factors technology for isolation and ex vivo expansion of human dental pulp stem cells for clinical translation |
3 |
| Bridging stem cell research and medicine: a learning health system |
3 |
| Embryonic-like regenerative phenomenon: wound-induced hair follicle neogenesis |
3 |
| Early natural history of neotissue formation in tissue-engineered vascular grafts in a murine model |
3 |
| Freeze-dried versus fresh platelet-rich plasma in acute wound healing of an animal model |
3 |
| Human umbilical cord blood cells restore vascular integrity in injured rat brain and modulate inflammation in vitro |
3 |
